Researchers from the GCAT'Genomes for Life project of the IGTP have analysed the genetic basis of 13 pigment traits and their association with diseases. The work has been published this month in Genes.
At the IGTP TODAY
The Public Health Agency of Catalonia (ASPCAT) has increased the budget granted to the Legionellosis Study Group (GELeg) of the Clinical and Environmental Infectious Diseases Research Group (CEID) of the Germans Trias i Pujol Research Institute (IGTP), ratifying its confidence in the resolution of Legionella outbreaks. The increase is almost double the budget items of previous years and will expand the scope of the work carried out in the laboratory.
NIMBLE Diagnostics, a spin-off from the Germans Trias i Pujol Research Institute (IGTP), the Polytechnic University of Catalonia – BarcelonaTech (UPC) and the University of Barcelona (UB), has successfully closed a funding round led by Grow Ventures together with Namarel Ventures and Inveniam Group where they have secured more than one million euros. NIMBLE is developing the first medical device to monitor patients with implanted stents, thus avoiding serious complications and improving the clinical management of millions of patients each year.
European Commission’s drive to launch a medical device created in the Hospital and the Germans Trias i Pujol Research Institute to improve the diagnosis and prognosis of the acute ischaemic stroke
The care and treatment provided to people who suffer an ischemic stroke can improve thanks to a technology developed in Catalonia. This is the purpose of Time is Brain (TiB), a start-up that arose from a scientific project carried out by the Hospital and the Germans Trias i Pujol Research Institute (IGTP), which has just received an investment by the European Union of almost 6 million euros in order for the hospitals to count on a pioneering device to manage acute ischaemic stroke.
Two studies from the Immunology group on autoimmunity and hematopoietic stem cells show promising therapeutic potential
The first study, published in Nanomedicine: Nanotechnology, Biology and Medicine, seeks a strategy to safely and definitevely restore self-tolerance in autoimmune diseases; the second, in Archivum Immunologiae et Therapiae Experimentalis, bets on making the most of umbilical cord blood cells, key against hematological diseases
The European Commission has granted two projects to the IGTP within the HORIZON programme, which add up to a total of 1,670,346 euros in funding and deal with the preclinical development of immunotherapies.
About thirty healthcare and research professionals from institutions belonging to the Can Ruti Campus, among the world’s most renowned scientists
Antoni Bayés, Pere Joan Cardona, Magí Farré, Miquel Àngel Gassull, Manel Puig-Domingo, Manuel Perucho and Jordi Barretina, all past and present members of IGTP staff together with nearly twenty other affiliated researchers and medical staff from Can Ruti Campus institutions -many affiliated to the IGTP- are included in Elsevier's Scopus list, composed of the 200,000 most renowned researchers worldwide.
A scientific project led by Beatriz Mothe receives the Young Researchers Award from the AstraZeneca Foundation
- The project aims to contribute to the design of more universal therapies for COVID-19 with efficacy in more vulnerable groups, such as people with immunosuppression
- The awards are an initiative to promote the development and consolidation of young scientific talent in Spain
Researchers from the Clinical Genomics group of the Germans Trias i Pujol Research Institute (IGTP) and the Genetics Service of the Germans Trias Hospital (HUGTiP) have developed a new in vitro therapy to recover part of the function encoded by the gene NF2, which, when altered, induces the development of neurofibromatosis type 2. The study has been published in the prestigious journal Molecular Therapy Nucleic Acids.
The Germans Trias i Pujol Research Institute (IGTP) and the Germans Trias Hospital participate in the HEAL project, which is funded through the Erasmus+ programme. HEAL is an ambitious project aimed at reformulating the way clinical internships currently take place in hospitals.